HD-OPM Archive
Hashtags

#moderna

2 posts

Personalized mRNA vaccine succeeds in phase 3 melanoma trial after ~50% phase 2 benefit

Aug 20, 2026 · Louis Nervegna ♥ 12 · 💬 12 Cancer

A personalized mRNA vaccine plus Keytruda improved recurrence-free and distant metastasis-free survival in a phase 3 trial of more than 1,100 patients with melanoma. The earlier phase 2 trial showed roughly a 50% reduction in recurrence or death at 5 years. Approval might come as early as 2027, and trials are under way in other cancers.